Published in Vaccine Weekly, July 7th, 1997
The study data, presented at the 13th European Immunology Meeting, held in Amsterdam, The Netherlands, during June 1997, showed an average 30-fold increase in functionally mature dendritic cells (DC) in the peripheral blood of subjects treated with Flt3 ligand. The increase in DC was detected as early as day 5 of treatment, peaking by day 9 to an...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly